BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

805 related articles for article (PubMed ID: 33006163)

  • 1. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19.
    Dobesh PP; Trujillo TC
    Pharmacotherapy; 2020 Nov; 40(11):1130-1151. PubMed ID: 33006163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
    Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.
    Parks AL; Auerbach AD; Schnipper JL; Anstey JE; Sterken DG; Hecht TEH; Fang MC;
    Thromb Res; 2020 Dec; 196():355-358. PubMed ID: 32977136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis.
    Hasan SS; Radford S; Kow CS; Zaidi STR
    J Thromb Thrombolysis; 2020 Nov; 50(4):814-821. PubMed ID: 32748122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.
    Del Borrello G; Giraudo I; Bondone C; Denina M; Garazzino S; Linari C; Mignone F; Pruccoli G; Scolfaro C; Spadea M; Pollio B; Saracco P
    J Thromb Haemost; 2021 Feb; 19(2):522-530. PubMed ID: 33305475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.
    Gu SX; Tyagi T; Jain K; Gu VW; Lee SH; Hwa JM; Kwan JM; Krause DS; Lee AI; Halene S; Martin KA; Chun HJ; Hwa J
    Nat Rev Cardiol; 2021 Mar; 18(3):194-209. PubMed ID: 33214651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: methodological issues and clinical implications.
    Kollias A; Kyriakoulis KG; Stergiou GS; Syrigos K
    Br J Haematol; 2020 Aug; 190(4):529-532. PubMed ID: 32621757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: coagulation disorders and anticoagulant treatment in patients hospitalised in ICU.
    Pluta J; Cieniewicz A; Trzebicki J
    Anaesthesiol Intensive Ther; 2021; 53(2):153-161. PubMed ID: 34006056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombotic Milieu, Thrombotic Events and Prophylactic Anticoagulation in Hospitalized COVID-19 Positive Patients: A Review.
    Cryer MJ; Farhan S; Kaufmann CC; Jäger B; Garg A; Krishnan P; Mehran R; Huber K
    Clin Appl Thromb Hemost; 2022; 28():10760296221074353. PubMed ID: 35068227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis and treatment of COVID-19 related venous thromboembolism.
    Kaptein FHJ; Stals MAM; Huisman MV; Klok FA
    Postgrad Med; 2021 Aug; 133(sup1):27-35. PubMed ID: 33657964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis.
    Dybowska M; Wyrostkiewicz D; Opoka L; Lewandowska K; Sobiecka M; Tomkowski W; Szturmowicz M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Anticoagulation on COVID-19 (SARS CoV-2) Patient Outcomes: A Systematic Review.
    Lazaridis D; Leung S; Kohler L; Smith CH; Kearson ML; Eraikhuemen N
    J Pharm Pract; 2022 Dec; 35(6):1000-1006. PubMed ID: 33960219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries.
    Ahmed HY; Papali A; Haile T; Shrestha GS; Schultz MJ; Lundeg G; Akrami KM;
    Am J Trop Med Hyg; 2021 Jan; 104(3_Suppl):99-109. PubMed ID: 33432908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
    Bocci MG; Maviglia R; Consalvo LM; Grieco DL; Montini L; Mercurio G; Nardi G; Pisapia L; Cutuli SL; Biasucci DG; Gori C; Rosenkranz R; De Candia E; Carelli S; Natalini D; Antonelli M; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12466-12479. PubMed ID: 33336766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system.
    Watson RA; Johnson DM; Dharia RN; Merli GJ; Doherty JU
    Hosp Pract (1995); 2020 Oct; 48(4):169-179. PubMed ID: 32429774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases.
    Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation in Cancer Patients: a Summary of Pitfalls to Avoid.
    Patel HK; Khorana AA
    Curr Oncol Rep; 2019 Feb; 21(2):18. PubMed ID: 30715628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.